Ongoing studies exploring the intricate relationship between oxidative stress, the Sirt-1/Nrf2 pathway, and PD are shedding light on viable therapeutic targets that offer hope for managing and alleviating this debilitating condition [9,10]. This evidence concerns the gene SIRT1 and Parkinson disease.